These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
256 related articles for article (PubMed ID: 30677071)
1. Thioguanine-based DENV-2 NS2B/NS3 protease inhibitors: Virtual screening, synthesis, biological evaluation and molecular modelling. Hariono M; Choi SB; Roslim RF; Nawi MS; Tan ML; Kamarulzaman EE; Mohamed N; Yusof R; Othman S; Abd Rahman N; Othman R; Wahab HA PLoS One; 2019; 14(1):e0210869. PubMed ID: 30677071 [TBL] [Abstract][Full Text] [Related]
2. In silico evaluation of inhibitory potential of triterpenoids from Azadirachta indica against therapeutic target of dengue virus, NS2B-NS3 protease. Dwivedi VD; Tripathi IP; Mishra SK J Vector Borne Dis; 2016; 53(2):156-61. PubMed ID: 27353586 [TBL] [Abstract][Full Text] [Related]
3. Dengue Virus NS2B/NS3 Protease Inhibitors Exploiting the Prime Side. Lin KH; Ali A; Rusere L; Soumana DI; Kurt Yilmaz N; Schiffer CA J Virol; 2017 May; 91(10):. PubMed ID: 28298600 [TBL] [Abstract][Full Text] [Related]
4. 3D-QSAR pharmacophore-based virtual screening, molecular docking and molecular dynamics simulation toward identifying lead compounds for NS2B-NS3 protease inhibitors. Luo PH; Zhang XR; Huang L; Yuan L; Zhou XZ; Gao X; Li LS J Recept Signal Transduct Res; 2017 Oct; 37(5):481-492. PubMed ID: 28758854 [TBL] [Abstract][Full Text] [Related]
5. Discovery of antiviral molecules for dengue: In silico search and biological evaluation. Cabarcas-Montalvo M; Maldonado-Rojas W; Montes-Grajales D; Bertel-Sevilla A; Wagner-Döbler I; Sztajer H; Reck M; Flechas-Alarcon M; Ocazionez R; Olivero-Verbel J Eur J Med Chem; 2016 Mar; 110():87-97. PubMed ID: 26807547 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of the inhibitory potency of anti-dengue phytocompounds against DENV-2 NS2B-NS3 protease: virtual screening, ADMET profiling and molecular dynamics simulation investigations. Purohit P; Barik D; Agasti S; Panda M; Meher BR J Biomol Struct Dyn; 2024 Apr; 42(6):2990-3009. PubMed ID: 37194462 [TBL] [Abstract][Full Text] [Related]
7. Design and docking studies of peptide inhibitors as potential antiviral drugs for dengue virus ns2b/ns3 protease. Velmurugan D; Mythily U; Rao K Protein Pept Lett; 2014; 21(8):815-27. PubMed ID: 23855663 [TBL] [Abstract][Full Text] [Related]
8. Targeting the DENV NS2B-NS3 protease with active antiviral phytocompounds: structure-based virtual screening, molecular docking and molecular dynamics simulation studies. Purohit P; Sahoo S; Panda M; Sahoo PS; Meher BR J Mol Model; 2022 Oct; 28(11):365. PubMed ID: 36274116 [TBL] [Abstract][Full Text] [Related]
9. Policresulen, a novel NS2B/NS3 protease inhibitor, effectively inhibits the replication of DENV2 virus in BHK-21 cells. Wu DW; Mao F; Ye Y; Li J; Xu CL; Luo XM; Chen J; Shen X Acta Pharmacol Sin; 2015 Sep; 36(9):1126-36. PubMed ID: 26279156 [TBL] [Abstract][Full Text] [Related]
10. Effects of NS2B-NS3 protease and furin inhibition on West Nile and Dengue virus replication. Kouretova J; Hammamy MZ; Epp A; Hardes K; Kallis S; Zhang L; Hilgenfeld R; Bartenschlager R; Steinmetzer T J Enzyme Inhib Med Chem; 2017 Dec; 32(1):712-721. PubMed ID: 28385094 [TBL] [Abstract][Full Text] [Related]
11. Identification of novel and potential inhibitors against the dengue virus NS2B/NS3 protease using virtual screening and biomolecular simulations. Nasir A; Samad A; Ajmal A; Li P; Islam M; Ullah S; Shah M; Bai Q Int J Biol Macromol; 2024 Jun; 272(Pt 1):132855. PubMed ID: 38834129 [TBL] [Abstract][Full Text] [Related]
12. Discovery of novel cyclic peptide inhibitors of dengue virus NS2B-NS3 protease with antiviral activity. Takagi Y; Matsui K; Nobori H; Maeda H; Sato A; Kurosu T; Orba Y; Sawa H; Hattori K; Higashino K; Numata Y; Yoshida Y Bioorg Med Chem Lett; 2017 Aug; 27(15):3586-3590. PubMed ID: 28539222 [TBL] [Abstract][Full Text] [Related]
13. Identification of a novel inhibitor of dengue virus protease through use of a virtual screening drug discovery Web portal. Viswanathan U; Tomlinson SM; Fonner JM; Mock SA; Watowich SJ J Chem Inf Model; 2014 Oct; 54(10):2816-25. PubMed ID: 25263519 [TBL] [Abstract][Full Text] [Related]
15. Structure-guided Discovery of a Novel Non-peptide Inhibitor of Dengue Virus NS2B-NS3 Protease. Li L; Basavannacharya C; Chan KW; Shang L; Vasudevan SG; Yin Z Chem Biol Drug Des; 2015 Sep; 86(3):255-64. PubMed ID: 25533891 [TBL] [Abstract][Full Text] [Related]
16. Proline-Based Allosteric Inhibitors of Zika and Dengue Virus NS2B/NS3 Proteases. Millies B; von Hammerstein F; Gellert A; Hammerschmidt S; Barthels F; Göppel U; Immerheiser M; Elgner F; Jung N; Basic M; Kersten C; Kiefer W; Bodem J; Hildt E; Windbergs M; Hellmich UA; Schirmeister T J Med Chem; 2019 Dec; 62(24):11359-11382. PubMed ID: 31769670 [TBL] [Abstract][Full Text] [Related]
17. Discovery of novel small molecule inhibitors of dengue viral NS2B-NS3 protease using virtual screening and scaffold hopping. Deng J; Li N; Liu H; Zuo Z; Liew OW; Xu W; Chen G; Tong X; Tang W; Zhu J; Zuo J; Jiang H; Yang CG; Li J; Zhu W J Med Chem; 2012 Jul; 55(14):6278-93. PubMed ID: 22742496 [TBL] [Abstract][Full Text] [Related]
18. In vitro evaluation of novel inhibitors against the NS2B-NS3 protease of dengue fever virus type 4. Nguyen TT; Lee S; Wang HK; Chen HY; Wu YT; Lin SC; Kim DW; Kim D Molecules; 2013 Dec; 18(12):15600-12. PubMed ID: 24352016 [TBL] [Abstract][Full Text] [Related]
19. Discovery and SAR studies of methionine-proline anilides as dengue virus NS2B-NS3 protease inhibitors. Zhou GC; Weng Z; Shao X; Liu F; Nie X; Liu J; Wang D; Wang C; Guo K Bioorg Med Chem Lett; 2013 Dec; 23(24):6549-54. PubMed ID: 24268549 [TBL] [Abstract][Full Text] [Related]